10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Brain Aromatization of Testosterone in the Male Syrian Hamster: Effects of Androgen and Photoperiod

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Estrogen formed by aromatization of testosterone (T) is involved in the activation of sexual behavior and control of the neuroendocrine system in the male Syrian hamster. Our study examined whether daylength influences formation of estrogen in the preoptic area (POA) and other neuroendocrine areas (anterior hypothalamus, AHT, and medial amygdala, MA) which are targets for T in behaviorally active males. Estrogen formation in individual brain samples was assayed in vitro using the stereospecific production of <sup>3</sup>H<sub>2</sub>O from (1β-<sup>3</sup>H) Tas a measurement of aromatase activity. Serum levels of PRL, LH, FSH and Twere compared with brain aromatase activity. Groups of intact, castrated and T-treated (chronic silastic T implants) male hamsters, previously selected on behavioral criteria as being sexually active, were maintained on long (16:8LD) or short (8:16LD) daylength for 16 weeks. Two further groups of males either intact or castrated and T-treated were shifted after 7 weeks from the long photoperiod to 12:12LD. POA, AHT and MA areas of sexually active males contained active aromatase systems which converted <sup>3</sup>H-T to estrogens. Enzyme activity differed between the areas (POA, MA > AHT). Aromatase activity was low in medial septum and cerebral samples. Castration, which reduced serum T to undetectable levels and elevated LH and FSH, had no effect on preoptic aromatase activity. Although estrogen formation in POA did not differ between 8:16LD and 16:8LD males, castration reduced aromatase activity in AHT of both short- and long-day groups. Aromatase activity in AHT was also significantly reduced in photo-inhibited 12:12LD intact males. There was no analogous decrease in 5α-reductase or 17β-hydroxysteroid dehydrogenase (HSD) activity, indicating a specific effect on the aromatase. The effect of photoperiod on aromatase activity was not reversed by T treatment. Therefore, photoinhibition acts in part through the effects of reduced T levels on the anterior hypothalamus, but it also acts independently of circulating T Our results suggest that both androgen and photoperiod may regulate the AHT aromatase system and that this occurs by different mechanisms. The more active aromatase system in POA is insensitive to both castration and photoperiod. Behavioral deficits in short-day males are not due to changes in the preoptic aromatase system, but may be related to changes in aromatase activity within AHT. We conclude that there is a difference in the regulation of two locally active aromatase systems within the preoptic-anterior hypothalamic complex of the male hamster.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1991
          1991
          04 April 2008
          : 53
          : 2
          : 194-203
          Affiliations
          aMRC Neuroendocrine Development and Behaviour Group, Institute of Animal Physiology and Genetics Research, Cambridge, UK; bDivision of Psychopharmacology, University Institute of Psychiatry, University of Geneva, Switzerland; cDepartment of Psychology, Vanderbilt University, Nashville, Tenn., USA; dDepartment of Anatomy, University of Cambridge, UK
          Article
          125718 Neuroendocrinology 1991;53:194–203
          10.1159/000125718
          1901634
          © 1991 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Original Paper

          Comments

          Comment on this article